The clinical impact of pitavastatin: comparative studies with other statins on LDL-C and HDL-C

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.6, 2012-04, pp. : 859-865

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identifying and Attaining LDL-C Goals: Mission Accomplished? Next Target: New Therapeutic Options to Raise HDL-C Levels

Current Drug Targets, Vol. 8, Iss. 3, 2007-01 ,pp. : 483-488

Bentham Science Publishers

Access to resources Recommend Favorite

Reduction of Serum LDL-C Levels: A Relationship to Clinical Benefits

By LaRosa J.C.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 4, 2003-01 ,pp. : 271-281

Adis International

Access to resources Recommend Favorite

Switch to rosuvastatin leads to greater LDL-C reduction

Inpharma, Vol. 1, Iss. 1436, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

HDL-C predictive of CV events in statin users

Inpharma, Vol. 1, Iss. 1609, 2007-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

New Drugs for HDL-C Disorders: The Beginning

Current Medicinal Chemistry, Vol. 21, Iss. 25, 2014-08 ,pp. : 2947-2951

Bentham Science Publishers

Access to resources Recommend Favorite